Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Nov, 18 2025
Jan, 9 2026
Jan, 11 2026
Aug, 20 2026
Apr, 9 2026